| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| IHC-Prediluted | NBP2-44980 | |||
| Azide and BSA Free | NBP2-34563-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26571-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21580-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82176-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21583-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21507-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21692-50ul | |||
![Immunohistochemistry-Paraffin: PELP1 Antibody [NB110-40622] - Section of human testicular seminoma. Antibody: Affinity purified rabbit antiPELP1/MNAR used at a dilution of 1:1,000 (1ug/ml). Detection: DAB.](http://images.novusbio.com/fullsize/PELP1-Antibody-Immunohistochemistry-Paraffin-NB110-40622-img0003.jpg "Immunohistochemistry-Paraffin: PELP1 Antibody [NB110-40622] - Section of human testicular seminoma. Antibody: Affinity purified rabbit antiPELP1/MNAR used at a dilution of 1:1,000 (1ug/ml). Detection: DAB.")
![<b>Independent Antibodies Validation. </b>Immunoprecipitation: PELP1 Antibody [NB110-40622] - Detection of Human PELP1/MNAR by Western Blot of Immunoprecipitates. Samples: Whole cell lysate (1 mg for IP, 20% of IP loaded) from HeLa cells. Antibodies: Affinity purified rabbit anti-PELP1/MNAR antibody NB110-40622 used for IP at 3 mcg/mg lysate. PELP1/MNAR was also immunoprecipitated by other rabbit anti-PELP1/MNAR antibodies, which recognize downstream epitopes. Detection: Chemiluminescence with an exposure time of 1 second.](http://images.novusbio.com/fullsize/PELP1-Antibody-Immunoprecipitation-NB110-40622-img0002.jpg)
![Immunohistochemistry-Paraffin: p53 Antibody (BP53-12 + DO-7) [NBP2-34309] - Formalin-fixed, paraffin-embedded human cervical carcinoma stained with P53 Monoclonal antibody (BP53-12 +DO-7)](http://images.novusbio.com/fullsize/p53-Antibody-BP53-12-+-DO-7-Immunohistochemistry-Paraffin-NBP2-34309-img0002.jpg "Immunohistochemistry-Paraffin: p53 Antibody (BP53-12 + DO-7) [NBP2-34309] - Formalin-fixed, paraffin-embedded human cervical carcinoma stained with P53 Monoclonal antibody (BP53-12 +DO-7)")
![Western Blot: BCL11B Antibody [NB600-263] - Detection of Human Bcl11b by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-Bcl11b antibody NB600-263 used for WB at 0.066 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.](http://images.novusbio.com/fullsize/BCL11B-Antibody-Western-Blot-NB600-263-img0006.jpg "<b>Biological Strategies Validation. </b>Western Blot: BCL11B Antibody [NB600-263] - Detection of Human Bcl11b by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibody: Affinity purified rabbit anti-Bcl11b antibody NB600-263 used for WB at 0.066 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: BCL11B Antibody [NB600-263] - Section of human stomach carcinoma. Antibody: Affinity purified rabbit anti-Bcl11b used at a dilution of 1:1,000 (1ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/BCL11B-Antibody-Immunohistochemistry-NB600-263-img0004.jpg)
![Immunoprecipitation: BCL11B Antibody [NB600-263] - Detection of Human Bcl11b on HeLa whole cell lysate using NB600-263. Bcl11b was also immunoprecipitated using affinity purified rabbit anti-Bcl11b antibodies NB600-262 and NB600-264.](http://images.novusbio.com/fullsize/BCL11B-Antibody-Immunoprecipitation-NB600-263-img0001.jpg)
![Western Blot: TFII-I Antibody [NB500-157] - Detection of Human GTF2I/TFII-I by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-GTF2I/TFII-I antibody NB500-157 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Western-Blot-NB500-157-img0007.jpg "Western Blot: TFII-I Antibody [NB500-157] - Detection of Human GTF2I/TFII-I by Western Blot. Samples: Whole cell lysate (50 ug) from HeLa and 293T cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-GTF2I/TFII-I antibody NB500-157 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.")
![Immunohistochemistry: TFII-I Antibody [NB500-157] - Sample: FFPE section of human breast carcinoma. Antibody: Affinity purified rabbit anti-GFT2I/TF II-I used at a dilution of 1:5,000 (0.2ug/ml). Detection: DAB](http://images.novusbio.com/fullsize/TFII-I-Antibody-Immunohistochemistry-NB500-157-img0006.jpg)
![<b>Genetic Strategies Validation. </b>Western Blot: TFII-I Antibody [NB500-157] - Whole cell lysate (100 ug) from HEK293 cells treated with GTF2I/TFII-I siRNA (+) or untreated (-). Antibody used at 0.2 ug/ml.](http://images.novusbio.com/fullsize/TFII-I-Antibody-Western-Blot-NB500-157-img0005.jpg)
![Immunohistochemistry: FOXO3 Antibody (1E2) [NBP3-26571] - Image of FOXO3 Antibody (1E2) diluted at 1:180 and staining in paraffin-embedded human endometrial cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26571_rabbit-foxo3-mab-1e2-2722024850466.jpg "Immunohistochemistry: FOXO3 Antibody (1E2) [NBP3-26571] - Image of FOXO3 Antibody (1E2) diluted at 1:180 and staining in paraffin-embedded human endometrial cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.")
![Immunohistochemistry: FOXO3 Antibody (1E2) [NBP3-26571] - Image of FOXO3 Antibody (1E2) diluted at 1:180 and staining in paraffin-embedded human endometrial cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26571_rabbit-foxo3-mab-1e2-2722024847198.jpg)
![Western Blot: FOXO3 Antibody (1E2) [NBP3-26571] - Positive Western Blot detected in: 293 whole cell lysate, Jurkat whole cell lysate, SH-SY5Y whole cell lysate, U87 whole cell lysate. All lanes: FOXO3 Antibody at 1.8ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 72, 49 KDa Observed band size: 72-90 KDa](http://images.novusbio.com/fullsize/nbp3-26571_rabbit-foxo3-mab-1e2-28220241136307.jpg)
![Immunocytochemistry/Immunofluorescence: FOXO3 Antibody (1E2) [NBP3-26571] - Staining of PC3 cells with FOXO3 Antibody (1E2) at 1:60, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26571_rabbit-foxo3-mab-1e2-28220241312244.jpg)
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 [p Ser106] Antibody [NB100-81912] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NB100-81912. The picture on the right is blocked with the phospho peptide.](http://images.novusbio.com/fullsize/nb100-81912_rabbit-polyclonal-er-alpha-nr3a1-p-ser106-antibody-23420241523257.jpg "Immunohistochemistry-Paraffin: ER alpha/NR3A1 [p Ser106] Antibody [NB100-81912] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NB100-81912. The picture on the right is blocked with the phospho peptide.")
![Western Blot: ER alpha/NR3A1 [p Ser106] Antibody [NB100-81912] - Western blot analysis of lysates from MCF7 cells, using NB100-81912. The lane on the left is blocked with the phospho peptide](http://images.novusbio.com/fullsize/antibody/nb100-81912_rabbit-polyclonal-er-alpha-nr3a1-p-ser106-antibody-western-blot-2342024154615..jpg)
![Western Blot: ER alpha/NR3A1 [p Ser106] Antibody [NB100-81912] - Western Blot analysis of RAT-BRAIN cells using NB100-81912 diluted at 1:500](http://images.novusbio.com/fullsize/nb100-81912_rabbit-polyclonal-er-alpha-nr3a1-p-ser106-antibody-103202523464527.jpg)
![Immunohistochemistry: Nrf2 [p Ser 40] Antibody (SR2277) [NBP3-21580] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NBP3-21580.](http://images.novusbio.com/fullsize/nbp3-21580_rabbit-nrf2-p-ser-40-mab-sr2277-5720231721512.jpg "Immunohistochemistry: Nrf2 [p Ser 40] Antibody (SR2277) [NBP3-21580] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NBP3-21580.")
![Western Blot: Nrf2 [p Ser 40] Antibody (SR2277) [NBP3-21580] - Western blot analysis using NBP3-21580 in HepG2 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21580_rabbit-nrf2-p-ser-40-mab-sr2277-67202310627.jpg)
![Immunocytochemistry/Immunofluorescence: Nrf2 [p Ser 40] Antibody (SR2277) [NBP3-21580] - Immunofluorescent analysis of HepG2 cells, using NBP3-21580.](http://images.novusbio.com/fullsize/nbp3-21580_rabbit-nrf2-p-ser-40-mab-sr2277-6720231051260.jpg)
![Western Blot: IRF7 Antibody (S04-1E1) [NBP3-19807] - Western blot detection of Rat Brain lysates using NBP3-19807. Predicted band size: 54kDa. Observed band size: 54kDa.](http://images.novusbio.com/fullsize/nbp3-19807_rabbit-irf7-mab-s04-1e1-103202523472622.jpg "Western Blot: IRF7 Antibody (S04-1E1) [NBP3-19807] - Western blot detection of Rat Brain lysates using NBP3-19807. Predicted band size: 54kDa. Observed band size: 54kDa.")
![Immunohistochemistry-Paraffin: IRF7 Antibody (S04-1E1) [NBP3-19807] - Immunohistochemistry of paraffin-embedded Human breast cancer tissue using NBP3-19807 at dilution 1/50](http://images.novusbio.com/fullsize/nbp3-19807_rabbit-irf7-mab-s04-1e1-103202523464517.jpg)
![Western Blot: RB1 [p Ser795] Antibody [NB100-82176] - Western blot analysis of extracts from K562 cells untreated(lane 1) or treated with serum(lane 2) using NB100-82176.](http://images.novusbio.com/fullsize/nb100-82176_rabbit-polyclonal-rb1-p-ser795-antibody-103202523472621.jpg "Western Blot: RB1 [p Ser795] Antibody [NB100-82176] - Western blot analysis of extracts from K562 cells untreated(lane 1) or treated with serum(lane 2) using NB100-82176.")
![Immunohistochemistry-Paraffin: RB1 [p Ser795] Antibody [NB100-82176] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using NB100-82176(left) or the same antibody preincubated with blocking peptide (right).](http://images.novusbio.com/fullsize/nb100-82176_rabbit-polyclonal-rb1-p-ser795-antibody-103202523464534.jpg)
![Immunocytochemistry/Immunofluorescence: RB1 [p Ser795] Antibody [NB100-82176] - Staining of methanol-fixed Hela cells using NB100-82176](http://images.novusbio.com/fullsize/nb100-82176_rabbit-polyclonal-rb1-p-ser795-antibody-113202515145461.jpg)
![Immunohistochemistry: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NBP3-21583.](http://images.novusbio.com/fullsize/nbp3-21583_rabbit-c-jun-p-ser-63-mab-sr1842-57202316112182.jpg "Immunohistochemistry: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NBP3-21583.")
![Western Blot: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Western blot analysis using NBP3-21583 in NIH/3T3 cell lysate treated with Anisomycin.](http://images.novusbio.com/fullsize/nbp3-21583_rabbit-c-jun-p-ser-63-mab-sr1842-5720231523499.jpg)
![Immunocytochemistry/Immunofluorescence: c-jun [p Ser 63] Antibody (SR1842) [NBP3-21583] - Immunofluorescent analysis of HeLa cells treated with anisomycin, using NBP3-21583.](http://images.novusbio.com/fullsize/nbp3-21583_rabbit-c-jun-p-ser-63-mab-sr1842-6720231051269.jpg)
![Immunohistochemistry: CREB [p Ser 133] Antibody (SR1800) [NBP3-21507] - Immunohistochemical analysis of paraffin-embedded human gastric carcinoma, using NBP3-21507.](http://images.novusbio.com/fullsize/nbp3-21507_rabbit-creb-p-ser-133-mab-sr1800-57202316494290.jpg "Immunohistochemistry: CREB [p Ser 133] Antibody (SR1800) [NBP3-21507] - Immunohistochemical analysis of paraffin-embedded human gastric carcinoma, using NBP3-21507.")
![Western Blot: CREB [p Ser 133] Antibody (SR1800) [NBP3-21507] - Western blot analysis using NBP3-21507 in HeLa cell lysates treated with Calyculin A.](http://images.novusbio.com/fullsize/nbp3-21507_rabbit-creb-p-ser-133-mab-sr1800-6720239533770.jpg)
![Immunohistochemistry: STAT5a/b Antibody (SR2282) [NBP3-21692] - Immunohistochemical analysis of paraffin-embedded human breast, using NBP3-21692.](http://images.novusbio.com/fullsize/nbp3-21692_rabbit-stat5a-b-mab-sr2282-5720231754843.jpg "Immunohistochemistry: STAT5a/b Antibody (SR2282) [NBP3-21692] - Immunohistochemical analysis of paraffin-embedded human breast, using NBP3-21692.")
![Western Blot: STAT5a/b Antibody (SR2282) [NBP3-21692] - Western blot analysis using NBP3-21692 in (1) Jurkat cell lysate; (2) 3T3 cell lysate; (2) PC12 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21692_rabbit-stat5a-b-mab-sr2282-57202317161850.jpg)